Article
New Directions for SMA Therapy
31 Aug 2018
Abstract excerpt
Spinal muscular atrophy (SMA) is a severe disorder of motor neurons and the most frequent genetic cause of mortality in childhood, due to respiratory complications. The disease occurs due to mutations in the survival motor neuron 1 (SMN1) gene that leads to a reduction in the SMN protein, causing degeneration of lower motor neurons, muscle weakness and atrophy. Recently, the Food and Drug Administration (FDA) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
